Clinical Trial Update: Tiragolumab, Atezolizumab and Chemotherapy in Triple Negative Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating tiragolumab in combination with atezolizumab and chemotherapy for triple-negative breast cancer is currently active but not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Tecentriq (atezolizumab)
• Tiragolumab (tiragolumab)

Snippet

Sponsor: Institut Curie | Conditions: Triple Negative Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING